BriaCell Therapeutics Corp. (BCTX) Shares Outstanding (2021 - 2026)

BriaCell Therapeutics has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $7.3 million in Q2 2026.

• Quarterly Shares Outstanding (Entity) rose 1840.96% year-over-year to $7.3 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $7.3 million (up 1840.96% YoY) and the FY2025 annual result came in at $423114.0, up 247.09% from the prior year.
• Shares Outstanding (Entity) improved to $7.3 million in Q2 2026 per BCTX's latest filing, from $2.8 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $7.3 million in Q2 2026 and troughed at $103459.0 in Q2 2022.
• A 5-year average of $798745.7 and a median of $106550.0 in 2023 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2026: Shares Outstanding (Entity) retreated 2.69% in 2023, then soared 1840.96% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $103459.0 in 2022, then rose by 2.99% to $106550.0 in 2023, then surged by 66.7% to $177616.0 in 2024, then jumped by 960.66% to $1.9 million in 2025, then soared by 284.86% to $7.3 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $7.3 million, $2.8 million, and $1.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.